UNIBO + IRCCS

Alma Mater Studiorum University of Bologna (UNIBO) and IRCCS Azienda Ospedaliero-Universitaria of Bologna are partecipating to the project PRIME-CKD. These entities will be involved in WP1, WP3, WP5, WP6, WP7. Thus, UNIBO and IRCCS will contribute to patients recruitment for the UVALID and CKD-bioMatch clinica studies and will be involved into the dissemination of results more specific for WP-5 to WP-7.